Variable 131I Activity in Multiple Hepatic Cysts in a Patient With Thyroid Cancer

被引:7
|
作者
Shao, Fuqiang [1 ,2 ,3 ]
Tang, Jiali [1 ]
Lan, Xiaoli [2 ,3 ]
机构
[1] Zigong First Peoples Hosp, Dept Nucl Med, Zigong, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Dept Nucl Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China
[3] Hubei Key Lab Mol Imaging, Wuhan, Hubei, Peoples R China
关键词
thyroid cancer; I-131; hepatic cyst; variable activity; WHOLE-BODY SCAN; RADIOIODINE UPTAKE; BRONCHOGENIC CYST; NABOTHIAN CYST; IODINE UPTAKE; LIVER; ACCUMULATION; METASTASIS; MIMICKING;
D O I
10.1097/RLU.0000000000002442
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Various etiologies could cause focal I-131 accumulation. Hepatic cyst is one of these etiologies. Here we present a 59-year-old man with a history of papillary thyroid cancer resection who received radioiodine therapy for three times. The images after the I-131 therapy of the second and third time showed variable activity uptake in the same hepatic cysts.
引用
收藏
页码:324 / 326
页数:3
相关论文
共 50 条
  • [1] Variable 131I Activity in Renal Stone in a Patient With Thyroid Cancer
    Liu, Shihong
    Chen, Li
    Zhang, Deping
    Cao, Chengjian
    Shao, Fuqiang
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 332 - 334
  • [2] Elevated 131I Activity in Adrenal Cyst in a Patient With Thyroid Cancer
    Liu, Wei
    Yang, Xiao
    Gong, Weidong
    Wang, Jianqiang
    Fan, Xueyuan
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 959 - 961
  • [3] Low activity treatment with 131I in differentiated thyroid cancer
    Olivan-Sasot, P.
    Prado-Wohlwend, S.
    Sanchez-Vano, R.
    Yepes-Agudelo, A.
    Agudelo-Cifuentes, M.
    Bernal-Vergara, J.
    Bello-Arques, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S608 - S609
  • [4] Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 697 - 699
  • [5] OPTIMISTIC LEFT HEMITHORAX 131I UPTAKE IN THYROID CANCER PATIENT
    Piciu, D.
    Pestean, C.
    Bara, A.
    Goia, C. Moisescu
    Roman, A.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2009, 5 (03) : 417 - 417
  • [6] Thyroid cancer radiotheragnostics: the case for activity adjusted 131I therapy
    Anca M. Avram
    Yuni K. Dewaraja
    Clinical and Translational Imaging, 2018, 6 : 335 - 346
  • [7] Thyroid cancer radiotheragnostics: the case for activity adjusted 131I therapy
    Avram, Anca M.
    Dewaraja, Yuni K.
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (05) : 335 - 346
  • [8] 131I radiation exposure and thyroid cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (01): : E9 - E9
  • [9] To Use or Not to Use 131I in Thyroid Cancer
    Metter, Darlene
    Phillips, William T.
    Walker, Ronald C.
    Blumhardt, Ralph
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (09) : 670 - 671
  • [10] 131I therapy of thyroid cancer patients
    Reiners, C
    Farahati, J
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 1999, 43 (04): : 324 - 335